pargyline has been researched along with Ataxia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foster, LL | 1 |
| Scott, WN | 1 |
1 other study available for pargyline and Ataxia
| Article | Year |
|---|---|
Observations on the effects of decaborane and several potential antidotes in the rat. SAM-TR-67-103.
Topics: Animals; Antidotes; Ataxia; Boron Compounds; Male; Methanol; Pargyline; Picolines; Pyridoxine; Rats; | 1967 |